Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaxart Inc (NQ: VXRT ) 0.6937 -0.0041 (-0.59%) Streaming Delayed Price Updated: 2:52 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vaxart Inc < Previous 1 2 3 4 5 6 7 8 Next > Vaxart: Oral Covid-19 Vaccine Is Interesting, But Questions Linger January 10, 2022 VXRT stock is more than a Covid-19 meme trade. But is there enough fundamentals there to support an investment heading into 2022? Via InvestorPlace Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street December 29, 2021 Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current Via Talk Markets Vaxart Deserves More Respect on Wall Street for Its Promising Covid-19 Vaccine December 21, 2021 As the Covid-19 vaccine maker expands into a second manufacturing facility, VXRT stock remains an undervalued gem. Via InvestorPlace Vaxart Stock Crosses 2 Key Levels Friday: What's Next? December 17, 2021 Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ... Via Benzinga Vaxart to Test Cross-Reactivity of its COVID-19 Oral Vaccine Against Omicron December 16, 2021 Vaxart Inc (NASDAQ: VXRT) plans to test the cross-reactivity of its oral tablet COVID-19 vaccine candidate against the omicron SARS-CoV-2 variant in two different... Via Benzinga Vaxart Stock Breaks Out Of Pennant Pattern: Now What? November 29, 2021 Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ... Via Benzinga Why Vaxart Stock Is About Ready To See A Breakout November 24, 2021 Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Wednes... Via Benzinga Vaxart Stock Is Being Squeezed At The End Of A Pattern November 18, 2021 Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Thursd... Via Benzinga VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down December 01, 2021 Despite a new factory acquisition, VXRT stock is down 9% on the day as 'Mad Money' host Jim Cramer warns investors about Vaxart. Via InvestorPlace Cramer Gives His Opinion On Nokia, Delta Air Lines And More December 01, 2021 On CNBC’s "Mad Money Lightning Round," Jim Cramer said DigitalOcean Holdings, Inc. (NYSE: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021 November 02, 2021 Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE: Via Benzinga Don’t Write Off Vaxart, As Its Oral Vaccine Still Has a Chance October 20, 2021 Vaxart stock is still worth a shot, as there's still big potential demand for a "no-needle" Covid-19 vaccine alternative. Via InvestorPlace Exposures COVID-19 Can This COVID Vaccine Stock Help Make You Rich? October 16, 2021 This biotech has a nifty trick potentially up its sleeve. Via The Motley Fool Exposures COVID-19 Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up October 12, 2021 Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesd... Via Benzinga NASDAQ:VLDR Shareholder Notice: Update in Lawsuit Against Velodyne Lidar, Inc. October 12, 2021 San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Velodyne Lidar, Inc. (NASDAQ:VLDR). Via SBWire Topics Lawsuit Exposures Financial Legal NASDAQ:VXRT Investor Alert: Update in Lawsuit Against Vaxart, Inc. October 12, 2021 San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Vaxart, Inc. (NASDAQ:VXRT). Via SBWire Topics Lawsuit Exposures COVID-19 Financial Legal Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late? October 10, 2021 The company is working on a vaccine candidate that doesn't involve a needle. Via The Motley Fool Why Vaxart Shares Are Trading Higher Today October 08, 2021 Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational... Via Benzinga 18 Stocks Moving in Friday's Pre-Market Session October 08, 2021 Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine... Via Benzinga Why Vaxart Shares Are Surging In Thursday's After-Hours Session October 07, 2021 Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRxiv showed that the... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session October 07, 2021 Gainers Vaxart (NASDAQ:VXRT) shares incr... Via Benzinga Why Vaxart Stock Tumbled in September October 07, 2021 A COVID-19 antiviral pill may undermine the biotech's value proposition. Via The Motley Fool Exposures COVID-19 Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial October 06, 2021 Vaxart Inc (NASDAQ: VXRT) has begun recruiting subjects for its Phase 2 COVID-19 oral tablet vaccine clinical trial. Related: FDA Clears Vaxart's... Via Benzinga Exposures COVID-19 Product Safety Why Investing in VXRT Stock is a Coin Flip October 06, 2021 Vaxart is a gamble for biotechnology investors, with its upside too dependent on the approval of an oral vaccine. Via InvestorPlace Exposures COVID-19 What's Going On With Vaxart's Stock? October 05, 2021 Vaxart Inc. (NASDAQ: VXRT) shares traded higher Tuesday after a study titled "A Phase 2 Trial With an Oral Tableted Covid-19 Vaccine" was posted to Clinicaltrials.gov.... Via Benzinga Exposures COVID-19 Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today October 01, 2021 Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector. Via InvestorPlace Exposures COVID-19 Vaxart Traders Should Not Dismiss the Vaccine Maker’s Momentum September 27, 2021 The recently range-bound price action of VXRT stock doesn't reflect the progress that Vaxart is making against Covid-19. Via InvestorPlace As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024 September 23, 2021 Via FinancialNewsMedia Exposures COVID-19 It’s Time to Start Thinking Seriously About Vaxart September 22, 2021 While VXRT stock is risky due to underlying clinical challenges, the evolving nature of Covid-19 makes it worth consideration. Via InvestorPlace Topics Government Exposures COVID-19 Political Vaxart Looks To Be On The Verge Of Breaking Out Of A Pattern September 13, 2021 Vaxart Inc. (NASDAQ: VXRT) shares are trading lower Monday, possibly after retail traders were able to push the stock higher. The stock looks to be almost breaking out of a... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.